Eastman Chemical (EMN) Gains from Investment Securities (2009 - 2026)

Eastman Chemical has reported Gains from Investment Securities for 18 years, with the latest figure at $4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Investment Securities rose 180.0% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at -$16.0 million (up 5.88% YoY), and the FY2025 full-year result was -$25.0 million, down 38.89% from the prior year.
• Gains from Investment Securities for Q1 2026 stood at $4.0 million, up from -$20.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $19.0 million in Q1 2023, with the low at -$30.0 million in Q3 2023.
• Historically, Gains from Investment Securities has averaged -$4.4 million across 5 years, with a median of -$5.5 million in 2022.
• The largest YoY upside for Gains from Investment Securities was 1200.0% in 2022 against a maximum downside of 850.0% in 2022.
• Eastman Chemical's Gains from Investment Securities stood at $13.0 million in 2022, then slumped by 161.54% to -$8.0 million in 2023, then tumbled by 125.0% to -$18.0 million in 2024, then retreated by 11.11% to -$20.0 million in 2025, then jumped by 120.0% to $4.0 million in 2026.
• The last three Gains from Investment Securities figures came in at $4.0 million (Q1 2026), -$20.0 million (Q4 2025), and -$5.0 million (Q1 2025), per Business Quant data.